FTC Asks To Drop Par, Paddock From AndroGel Antitrust Row
The Federal Trade Commission on Thursday sought to drop Paddock Holdings and Endo subsidiary Par Pharmaceutical from a Georgia federal court case in which it alleges pharmaceutical companies illegally conspired to...To view the full article, register now.
Already a subscriber? Click here to view full article